The US Food and Drug Administration (FDA) may approve some cancer drugs on the basis of trials with suboptimal control arms according to a new research conclusion from investigators associated with Oregon Health & Science University and Mayo Clinic Arizona....
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
